📰 Ioscience News
Page 21 - Ioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ioscience. Real-time updates on events, politics, business and more.
May 9, 2022
DJ Clinical Development Update from Portfolio Company LogicBio Arix Bioscience PLC (ARIX) Clinical Development Update from Portfolio Company LogicBio 09-May-2022 / 15:28 GMT/BST Dissemination of
April 30, 2022
Toronto, Ontario--(Newsfile Corp. - April 29, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change
April 29, 2022
DJ Unaudited NAV and Notice of Financial Results Arix Bioscience PLC (ARIX) Unaudited NAV and Notice of Financial Results 29-Apr-2022 / 10:44 GMT/BST Dissemination of a Regulatory Announcement, transmitted
April 21, 2022
25th patent grant is Lexaria's first-ever patent for the enhanced delivery of antiviralsKELOWNA, BC / ACCESSWIRE / April 21, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company"
April 19, 2022
HYPER-H21-4 will evaluate DehydraTECHTM-CBD for reducing blood pressure together with other potential clinical benefitsThis study is designed to enhance Lexaria's probabilities of success with its expected
April 14, 2022
Data From This Human Study, Together With the Findings From Lexaria's Other Previously Announced Successful Studies, Intended To Support the Company's Plans To Seek Approvals by the U.S. Food and Drug
April 12, 2022
This Press Release Replaces the Press Release Issued Earlier Today and Includes an Update to the Company Name (AgMedica Bioscience) in the HeadlineVANCOUVER, BC / ACCESSWIRE / April 12, 2022 / Silver Phoenix
April 12, 2022
VANCOUVER, BC / ACCESSWIRE / April 12, 2022 / Silver Phoenix Resources Inc. (CSE:SP) ("SPR" or the "Company") is pleased to announce that it has entered into a binding memorandum of understanding dated
April 12, 2022
Lexaria's DehydraTECH-nicotine pouch performance will be compared to existing leading brands currently sold in the United States such as ON! and ZynKELOWNA, BC / ACCESSWIRE / April 12, 2022 / Lexaria Bioscience
April 11, 2022
KELOWNA, BC / ACCESSWIRE / April 11, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has entered new